Home › Funds › Renaissance Technologies › CTOR
Renaissance Technologies position in CTOR
CLOVIS ONCOLOGY INC · Health Care
Latest position (Q3 2025)55.90K sh
Reported value held$113.48K
Portfolio Weight0.00%
First reportedQ4 2024
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 11.20K | $12.88K | New |
| Q3 2025 | 55.90K | $113.48K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CTOR
- Bank of America Corp 3.84M sh · $2.49M · Q2 2026
- Vanguard Group 597.00K sh · $597.00K · Q4 2025
- UBS Group AG 334.62K sh · $217.50K · Q2 2026
- Geode Capital Management 245.41K sh · $159.54K · Q2 2026
- Citadel Advisors 90.59K sh · $58.89K · Q2 2026
- Northern Trust Corp 45.75K sh · $29.74K · Q2 2026
- Wells Fargo & Co 500 sh · $325 · Q2 2026
- Morgan Stanley 23 sh · $15 · Q2 2026